Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

Similar articles for PubMed (Select 22483802)

1.

The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments.

Zhang JG, Czabotar PE, Policheni AN, Caminschi I, Wan SS, Kitsoulis S, Tullett KM, Robin AY, Brammananth R, van Delft MF, Lu J, O'Reilly LA, Josefsson EC, Kile BT, Chin WJ, Mintern JD, Olshina MA, Wong W, Baum J, Wright MD, Huang DC, Mohandas N, Coppel RL, Colman PM, Nicola NA, Shortman K, Lahoud MH.

Immunity. 2012 Apr 20;36(4):646-57. doi: 10.1016/j.immuni.2012.03.009. Epub 2012 Apr 5.

2.

Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.

Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, Rosewell I, Reis e Sousa C.

Nature. 2009 Apr 16;458(7240):899-903. doi: 10.1038/nature07750.

3.

Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.

Lahoud MH, Ahmet F, Kitsoulis S, Wan SS, Vremec D, Lee CN, Phipson B, Shi W, Smyth GK, Lew AM, Kato Y, Mueller SN, Davey GM, Heath WR, Shortman K, Caminschi I.

J Immunol. 2011 Jul 15;187(2):842-50. doi: 10.4049/jimmunol.1101176. Epub 2011 Jun 15.

4.

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells.

Schreibelt G, Klinkenberg LJ, Cruz LJ, Tacken PJ, Tel J, Kreutz M, Adema GJ, Brown GD, Figdor CG, de Vries IJ.

Blood. 2012 Mar 8;119(10):2284-92. doi: 10.1182/blood-2011-08-373944. Epub 2012 Jan 10.

5.

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement.

Caminschi I, Proietto AI, Ahmet F, Kitsoulis S, Shin Teh J, Lo JC, Rizzitelli A, Wu L, Vremec D, van Dommelen SL, Campbell IK, Maraskovsky E, Braley H, Davey GM, Mottram P, van de Velde N, Jensen K, Lew AM, Wright MD, Heath WR, Shortman K, Lahoud MH.

Blood. 2008 Oct 15;112(8):3264-73. doi: 10.1182/blood-2008-05-155176. Epub 2008 Jul 30.

6.

Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.

Caminschi I, Vremec D, Ahmet F, Lahoud MH, Villadangos JA, Murphy KM, Heath WR, Shortman K.

Mol Immunol. 2012 Feb;50(1-2):9-17. doi: 10.1016/j.molimm.2011.11.008. Epub 2011 Dec 29.

PMID:
22209163
7.

F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells.

Ahrens S, Zelenay S, Sancho D, Hanč P, Kjær S, Feest C, Fletcher G, Durkin C, Postigo A, Skehel M, Batista F, Thompson B, Way M, Reis e Sousa C, Schulz O.

Immunity. 2012 Apr 20;36(4):635-45. doi: 10.1016/j.immuni.2012.03.008. Epub 2012 Apr 5.

8.

CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes.

Huysamen C, Willment JA, Dennehy KM, Brown GD.

J Biol Chem. 2008 Jun 13;283(24):16693-701. doi: 10.1074/jbc.M709923200. Epub 2008 Apr 11.

10.

The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.

Kambayashi T, Kraft-Leavy JR, Dauner JG, Sullivan BA, Laur O, Jensen PE.

J Immunol. 2004 Feb 1;172(3):1661-9.

11.

Enhancing immune responses by targeting antigen to DC.

Caminschi I, Lahoud MH, Shortman K.

Eur J Immunol. 2009 Apr;39(4):931-8. doi: 10.1002/eji.200839035.

PMID:
19197943
12.

Immunology: Actin' dangerously.

Brown GD.

Nature. 2012 May 31;485(7400):589-90. doi: 10.1038/485589a. No abstract available.

PMID:
22660316
13.

Enhanced dendritic cell-induced immune responses mediated by the novel C-type lectin receptor mDCAR1.

Kaden SA, Kurig S, Vasters K, Hofmann K, Zaenker KS, Schmitz J, Winkels G.

J Immunol. 2009 Oct 15;183(8):5069-78. doi: 10.4049/jimmunol.0900908. Epub 2009 Sep 28.

14.

Structure of the Complex of F-Actin and DNGR-1, a C-Type Lectin Receptor Involved in Dendritic Cell Cross-Presentation of Dead Cell-Associated Antigens.

Hanč P, Fujii T, Iborra S, Yamada Y, Huotari J, Schulz O, Ahrens S, Kjær S, Way M, Sancho D, Namba K, Reis E Sousa C.

Immunity. 2015 May 19;42(5):839-49. doi: 10.1016/j.immuni.2015.04.009. Epub 2015 May 12.

PMID:
25979418
15.

APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif.

Bates EE, Fournier N, Garcia E, Valladeau J, Durand I, Pin JJ, Zurawski SM, Patel S, Abrams JS, Lebecque S, Garrone P, Saeland S.

J Immunol. 1999 Aug 15;163(4):1973-83.

16.

Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4.

Ryan EJ, Marshall AJ, Magaletti D, Floyd H, Draves KE, Olson NE, Clark EA.

J Immunol. 2002 Nov 15;169(10):5638-48.

17.
18.

Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria.

Piva L, Tetlak P, Claser C, Karjalainen K, Renia L, Ruedl C.

J Immunol. 2012 Aug 1;189(3):1128-32. doi: 10.4049/jimmunol.1201171. Epub 2012 Jun 25.

19.

C-Type Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation.

Miyake Y, Masatsugu OH, Yamasaki S.

J Immunol. 2015 Jun 1;194(11):5366-74. doi: 10.4049/jimmunol.1402429. Epub 2015 Apr 17.

PMID:
25888641
20.

DCIR acts as an inhibitory receptor depending on its immunoreceptor tyrosine-based inhibitory motif.

Kanazawa N, Okazaki T, Nishimura H, Tashiro K, Inaba K, Miyachi Y.

J Invest Dermatol. 2002 Feb;118(2):261-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk